Literature DB >> 22542845

Connective tissue growth factor causes glaucoma by modifying the actin cytoskeleton of the trabecular meshwork.

Benjamin Junglas1, Sabrina Kuespert, Amin A Seleem, Tobias Struller, Sabrina Ullmann, Michael Bösl, Anja Bosserhoff, Josef Köstler, Ralf Wagner, Ernst R Tamm, Rudolf Fuchshofer.   

Abstract

The most critical risk factor for optic nerve damage in cases of primary open-angle glaucoma (POAG) is an increased intraocular pressure (IOP) caused by a resistance to aqueous humor outflow in the trabecular meshwork (TM). The molecular pathogenesis of this increase in outflow resistance in POAG has not yet been identified, but it may involve transforming growth factor TGF-β2, which is found in higher amounts in the aqueous humor of patients with POAG. Connective tissue growth factor (CTGF) is a TGF-β2 target gene with high constitutive TM expression. In this study, we show that either adenoviral-mediated or transgenic CTGF overexpression in the mouse eye increases IOP and leads to optic nerve damage. CTGF induces TM fibronectin and α-SMA in animals, whereas actin stress fibers and contractility are both induced in cultured TM cells. Depletion of CTGF by RNA interference leads to a marked attenuation of the actin cytoskeleton. Rho kinase inhibitors cause a reversible decline in the IOP of CTGF-overexpressing mice to levels seen in control littermates. Overall, the effects of CTGF on IOP appear to be caused by a modification of the TM actin cytoskeleton. CTGF-overexpressing mice provide a model that mimics the essential functional and structural aspects of POAG and offer a molecular mechanism to explain the increase of its most critical risk factor.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22542845     DOI: 10.1016/j.ajpath.2012.02.030

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  97 in total

Review 1.  Deconstructing aqueous humor outflow - The last 50 years.

Authors:  Paul L Kaufman
Journal:  Exp Eye Res       Date:  2020-06-23       Impact factor: 3.467

2.  Primary Open-Angle Glaucoma: A Transforming Growth Factor-β Pathway-Mediated Disease.

Authors:  Andrew W Taylor
Journal:  Am J Pathol       Date:  2012-04-21       Impact factor: 4.307

Review 3.  Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.

Authors:  Rebecca K Donegan; Raquel L Lieberman
Journal:  J Med Chem       Date:  2015-09-25       Impact factor: 7.446

4.  Thermally labile components of aqueous humor potently induce osteogenic potential in adipose-derived mesenchymal stem cells.

Authors:  Joshua T Morgan; Heung Sun Kwon; Joshua A Wood; Dori L Borjesson; Stanislav I Tomarev; Christopher J Murphy; Paul Russell
Journal:  Exp Eye Res       Date:  2015-02-24       Impact factor: 3.467

Review 5.  Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma.

Authors:  Ponugoti Vasantha Rao
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-27       Impact factor: 2.671

6.  RhoA GTPase-induced ocular hypertension in a rodent model is associated with increased fibrogenic activity in the trabecular meshwork.

Authors:  Padmanabhan P Pattabiraman; Tommy Rinkoski; Eric Poeschla; Alan Proia; Pratap Challa; Ponugoti V Rao
Journal:  Am J Pathol       Date:  2014-12-12       Impact factor: 4.307

7.  Improvement in outflow facility by two novel microinvasive glaucoma surgery implants.

Authors:  Cassandra L Hays; Vikas Gulati; Shan Fan; Thomas W Samuelson; Iqbal Ike K Ahmed; Carol B Toris
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-28       Impact factor: 4.799

8.  Role of substratum stiffness in modulating genes associated with extracellular matrix and mechanotransducers YAP and TAZ.

Authors:  Vijay Krishna Raghunathan; Joshua T Morgan; Britta Dreier; Christopher M Reilly; Sara M Thomasy; Joshua A Wood; Irene Ly; Binh C Tuyen; Marissa Hughbanks; Christopher J Murphy; Paul Russell
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-14       Impact factor: 4.799

9.  Intracameral Delivery of Layer-by-Layer Coated siRNA Nanoparticles for Glaucoma Therapy.

Authors:  Andrea E Dillinger; Michaela Guter; Franziska Froemel; Gregor R Weber; Kristin Perkumas; W Daniel Stamer; Andreas Ohlmann; Rudolf Fuchshofer; Miriam Breunig
Journal:  Small       Date:  2018-10-23       Impact factor: 13.281

Review 10.  Development of diagnostic and treatment strategies for glaucoma through understanding and modification of scleral and lamina cribrosa connective tissue.

Authors:  Harry A Quigley; Frances E Cone
Journal:  Cell Tissue Res       Date:  2013-03-28       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.